According to the law firm press release, Envision Healthcare Corporation provides health care services. The Hospital offers surgery, pharmacy, medical imaging, emergency care, and other related health care services. Envision Healthcare serves patients in the United States. At all relevant times, EmCare Holdings, Inc. (“EmCare”) has been one of the Company’s primary operating subsidiaries.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) EmCare routinely arranged for patients who sought treatment at in-network facilities to be treated by out-of-network physicians; (ii) EmCare accordingly billed these patients at higher rates than if the patients had received treatment from in-network physicians; (iii) the Company’s statements attributing EmCare’s Class Period growth to other factors were therefore false and/or misleading; (iv) Envision’s EmCare revenues were likely to be unsustainable after the foregoing conduct came to light; and (v) as a result of the foregoing, Envision’s public statements were materially false and misleading at all relevant times.

On October 27, 2017, the Court appointed Lead Plaintiffs and Counsel. On November 7, the Court issued an Order consolidating cases. On January 26, 2018, Lead Plaintiffs filed a consolidated Complaint. Defendants filed Motions to Dismiss the consolidated Complaint on April 3. On November 19, 2019, the Court issued an Order granting in part and denying in part Defendants' Motions to Dismiss.

On December 13, 2021, Plaintiffs filed an amended consolidated Complaint. Defendants filed a Motion to Dismiss the amended consolidated Complaint on January 10, 2022. On September 29, the Court issued an Order denying Defendants' Motion to Dismiss.

On May 15, 2023, the case was stayed due to proceedings in the United States Bankruptcy Court for the Southern District of Texas.

On September 22, 2023, the parties entered into a Stipulation of Settlement. The Court granted preliminary approval of the Settlement on November 20. On March 21, 2024, the Court granted final approval of the Settlement, including an award of Attorneys’ Fees and Expenses, and entered Final Judgment.